An Extended Access Program for Perampanel

Trial Profile

An Extended Access Program for Perampanel

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Perampanel (Primary)
  • Indications Partial epilepsies
  • Focus Expanded access; Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 11 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top